Baclofen Effects on Marijuana Dependence

Status Completed

Clinical Trial Summary

Studies show that certain reminders of drug use such as the sight of someone using marijuana, pictures of blunts, particular moments throughout the day, prompt marijuana users to smoke marijuana. We are measuring the brain and behavioral responses of marijuana dependent individuals to these reminders (cues) We will examine brain responses during cue exposure and determine whether these responses are associated with treatment outcome.

We are testing the hypothesis that the medication baclofen reduces brain responses during marijuana cue exposure and/or craving in marijuana dependent individuals. Baclofen is FDA-approved for other uses, but not for the treatment of marijuana dependence. Functional magnetic resonance imaging (fMRI) will be used to measure the brain's response to marijuana cues. fMRI is a painless technique that takes special pictures of the brain (or other parts of your body). It does not involve radiation or injections.

Eligible participants will have a 50% chance of receiving placebo (sugar pill) and a 50% chance of receiving baclofen. Neither the participant nor study personnel will know whether participants are receiving baclofen or placebo. Participants will also receive twice weekly psychosocial treatment with a certified clinician. Twelve weeks of treatment will be followed by a 12 week follow up.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02011516
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Completed
Phase	Phase 2
Start date	December 2013
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00875836` - Buspirone Treatment for Marijuana Dependence	Phase 4
Completed	`NCT00893269` - The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep	Phase 1
Completed	`NCT00490269` - Ph1 Marinol Interaction Study - Part 2 - 1	Phase 1
Completed	`NCT02579421` - Hormones and Reduction in Co-users of Marijuana and Nicotine	N/A
Terminated	`NCT01598896` - Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia	Phase 2/Phase 3
Completed	`NCT00373295` - Effect of Baclofen on Marijuana Withdrawal and Relapse	Phase 2
Active, not recruiting	`NCT01827332` - Effect of Oxytocin on Craving and Therapy Response	N/A
Completed	`NCT01335789` - Effect of Oxytocin on Stress in Marijuana Users	N/A
Terminated	`NCT00438139` - Ph1 Marinol Interaction Study - Part 1 - 1	Phase 1
Completed	`NCT02955329` - Vaping THC From Electronic Cigarettes	Phase 3
Completed	`NCT02439814` - Pregnenolone and Marijuana Dependence	Phase 2
Completed	`NCT01347762` - Nabilone for Cannabis Dependence: A Pilot Study	Phase 2/Phase 3
Completed	`NCT01039415` - Attempts to Stop/Reduce Marijuana Among Dependent Users	N/A
Completed	`NCT00270803` - The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana	N/A
Completed	`NCT01020019` - Combined Pharmacotherapy for Cannabis Dependency	Phase 2/Phase 3
Completed	`NCT02030665` - Marijuana Treatment Project 4	N/A
Completed	`NCT00107588` - Marijuana Treatment Project - 3	N/A
Recruiting	`NCT00598052` - Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy	N/A
Completed	`NCT00350649` - Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management	Phase 2
Completed	`NCT00374127` - Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper	Phase 2